EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quadruple-negative autoantibody status and interstitial lung disease progression in systemic sclerosis

Takeshi Kawaguchi iD, Kunihiko Umekita iD, Masayuki Murai iD, Chihiro Iwao, Masatoshi Kimura iD, Michikazu Nakai, Taiga Miyazaki iD

Rheumatology Advances in Practice · 21.09.2026 · 10 (4)

DOI: 10.1093/rap/rkag127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology Advances in Practice, online erschienen am 24.10.2026. Verfasst von Takeshi Kawaguchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respirology, Rheumatology, Infectious Diseases and Neurology, Department of Internal Medicine, Faculty of Medicine. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Miyazaki Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the association between disease-specific autoantibody profiles and disease progression in systemic sclerosis-associated interstitial lung disease (SSc-ILD), with a focus on a quadruple-negative phenotype.

Methods

This retrospective cohort study included 80 patients with SSc-ILD who were followed for at least 12 months at a single tertiary centre. ILD progression was defined according to the OMERACT criteria and/or worsening on high-resolution computed tomography. Autoantibody status was categorized based on four antibodies: anti-topoisomerase I, anti-centromere, anti-RNA polymerase III and anti-U1-RNP. Quadruple-negative (QN) was defined as negativity for all four antibodies. Factors associated with ILD progression were evaluated using multivariable logistic regression. Exploratory comprehensive autoantibody profiling was performed in patients with available stored serum samples.

Results

During a median follow-up of 44.5 months, disease progression occurred in 32 of 80 patients with SSc-ILD. Anti-centromere antibody (ACA) positivity was associated with a lower risk of progression, whereas anti-topoisomerase I antibody positivity was not associated with disease progression (Model 2: OR 3.19, 95% CI 0.70–14.60). Compared with ACA positivity, QN status was associated with ILD progression (Model 2: OR 10.40, 95% confidence interval [CI] 1.77–60.70). However, CIs were wide. Exploratory analyses showed a high prevalence of anti-Ro-52 antibody positivity among patients with QN status.

Conclusion

QN autoantibody status may be associated with an increased risk of ILD progression in SSc. The QN status may represent a heterogeneous serological category that could help identify patients who require closer clinical monitoring. However, these results are hypothesis-generating and require validation in larger, independent cohorts.

Schlagwörter

Stichwörter der Autor:innen

autoantibody profilesdisease progressioninterstitial lung diseasequadruple-negativesystemic sclerosis

Autor:innen und Institutionen

  • Division of Respirology, Rheumatology, Infectious Diseases and Neurology, Department of Internal Medicine, Faculty of Medicine.
  • Department of Statistics and Data Management, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

ORCID-Profile: Takeshi Kawaguchi, Kunihiko Umekita, Masayuki Murai, Masatoshi Kimura, Taiga Miyazaki

Förderung

  • University of Miyazaki Hospital

Zitieren

APA

Kawaguchi, T., Umekita, K., Murai, M., Iwao, C., Kimura, M., Nakai, M., & Miyazaki, T. (2026). Quadruple-negative autoantibody status and interstitial lung disease progression in systemic sclerosis. Rheumatology Advances in Practice, 10(4). https://doi.org/10.1093/rap/rkag127

Vancouver

Kawaguchi T, Umekita K, Murai M, Iwao C, Kimura M, Nakai M, et al. Quadruple-negative autoantibody status and interstitial lung disease progression in systemic sclerosis. Rheumatology Advances in Practice. 2026;10(4). doi:10.1093/rap/rkag127

BibTeX
@article{Kawaguchi2026,
  author = {Kawaguchi, Takeshi and Umekita, Kunihiko and Murai, Masayuki and Iwao, Chihiro and Kimura, Masatoshi and Nakai, Michikazu and Miyazaki, Taiga},
  title = {Quadruple-negative autoantibody status and interstitial lung disease progression in systemic sclerosis},
  journal = {Rheumatology Advances in Practice},
  year = {2026},
  volume = {10},
  number = {4},
  doi = {10.1093/rap/rkag127}
}
Kostenlos starten →